LAKE CHARLES, La. (KPLC) - A recent booking report has highlighted ongoing concerns about a Southwest Louisiana transitional work program and its history of inmates walking off job sites. Paul Nathan ...

DAVENPORT, Iowa (KWQC) - Three newborn kittens found abandoned in a cardboard box on the side of a road are getting a second chance at life thanks to a local foster family and animal welfare ...

Nigeria installed 803 megawatts of new solar capacity in 2025, a rise of 141 per cent on the previous year, making it Africa’s second-largest solar market behind South Africa, according to the Global ...

AUBURN, Ala. – Auburn Athletics posted its highest Graduation Success Rate (GSR) in program history, 94 percent, exceeding Auburn's record-setting 93-percent rates from 2021 and 2022, the NCAA ...

Shimron Hetmyer survived two dropped chances on Monday as his 85 off just 34 balls and brutal hitting from Rovman Powell and Sherfane Rutherford powered West Indies to a mammoth 254/6 in 20 overs ...

The NHS is facing a “second surge” of norovirus as cases of the vomiting bug reach their highest level so far this winter. NHS figures published today show the average number of patients in hospital ...

LUXEMBOURG, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”) announced today that it has decided to terminate, effective on March 3, 2026, the second ...

Chicago, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Second Century Ventures, the strategic investment arm of the National Association of REALTORS ®, has opened applications for the 2026 REACH Commercial ...

LOS ANGELES (AP) — Nearly a year after helping Auburn reach the Final Four, Chad Baker-Mazara is no longer a member of Southern California's basketball program, the team said Sunday. He was the second ...

Mount Olive made sure history didn’t repeat itself. The No. 12 ranked Marauders downed Toms River East 47-22 in the 2026 NJSIAA/IBEW Local 102 Group 4 state final. It’s Mount Olive’s second title in ...

Milestone achieved in Scribe and Lilly’s ongoing collaboration to develop in vivo CRISPR-based therapeutics for neurological and neuromuscular diseases Achievement validates Scribe’s technologies and ...